Partner Content Partner Content SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – S... SMi’s 22nd Annual Superbugs & Superdrugs Conference
Partner Content Partner Content SMi’s Exclusive Interview with Mark Albrecht just released SMi Reports: An exclusive interview with Biomedical Adv
Events Partner Content Superbugs & Superdrugs USA Superbugs & Superdrugs USA November 12 – 13, 2018 New Jersey, USA
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.